1. Home
  2. LND vs CELC Comparison

LND vs CELC Comparison

Compare LND & CELC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LND
  • CELC
  • Stock Information
  • Founded
  • LND 2005
  • CELC 2011
  • Country
  • LND Brazil
  • CELC United States
  • Employees
  • LND N/A
  • CELC N/A
  • Industry
  • LND Farming/Seeds/Milling
  • CELC Medical Specialities
  • Sector
  • LND Consumer Staples
  • CELC Health Care
  • Exchange
  • LND Nasdaq
  • CELC Nasdaq
  • Market Cap
  • LND 376.5M
  • CELC 377.8M
  • IPO Year
  • LND 2006
  • CELC 2017
  • Fundamental
  • Price
  • LND $3.60
  • CELC $10.03
  • Analyst Decision
  • LND
  • CELC Strong Buy
  • Analyst Count
  • LND 0
  • CELC 6
  • Target Price
  • LND N/A
  • CELC $30.17
  • AVG Volume (30 Days)
  • LND 43.4K
  • CELC 291.6K
  • Earning Date
  • LND 05-07-2025
  • CELC 03-26-2025
  • Dividend Yield
  • LND 6.85%
  • CELC N/A
  • EPS Growth
  • LND 5.56
  • CELC N/A
  • EPS
  • LND 0.45
  • CELC N/A
  • Revenue
  • LND $191,133,083.00
  • CELC N/A
  • Revenue This Year
  • LND $55.76
  • CELC N/A
  • Revenue Next Year
  • LND N/A
  • CELC N/A
  • P/E Ratio
  • LND $8.09
  • CELC N/A
  • Revenue Growth
  • LND N/A
  • CELC N/A
  • 52 Week Low
  • LND $3.49
  • CELC $8.53
  • 52 Week High
  • LND $5.20
  • CELC $22.19
  • Technical
  • Relative Strength Index (RSI)
  • LND 41.95
  • CELC 42.28
  • Support Level
  • LND $3.49
  • CELC $9.61
  • Resistance Level
  • LND $3.96
  • CELC $10.89
  • Average True Range (ATR)
  • LND 0.13
  • CELC 1.08
  • MACD
  • LND -0.00
  • CELC 0.03
  • Stochastic Oscillator
  • LND 23.40
  • CELC 32.26

About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.

About CELC Celcuity Inc.

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.

Share on Social Networks: